172 related articles for article (PubMed ID: 34742397)
1. Exploring the design space of AAV transient-transfection in suspension cell lines.
Meade O; Clark J; McCutchen M; Kerwin J
Methods Enzymol; 2021; 660():341-360. PubMed ID: 34742397
[TBL] [Abstract][Full Text] [Related]
2. Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing.
Selvaraj N; Wang CK; Bowser B; Broadt T; Shaban S; Burns J; Saptharishi N; Pechan P; Golebiowski D; Alimardanov A; Yang N; Mitra G; Vepachedu R
Hum Gene Ther; 2021 Aug; 32(15-16):850-861. PubMed ID: 33397196
[TBL] [Abstract][Full Text] [Related]
3. Production of adeno-associated viral vector serotype 6 by triple transfection of suspension HEK293 cells at higher cell densities.
Moço PD; Xu X; Silva CAT; Kamen AA
Biotechnol J; 2023 Sep; 18(9):e2300051. PubMed ID: 37337925
[TBL] [Abstract][Full Text] [Related]
4. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
Grieger JC; Soltys SM; Samulski RJ
Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
[TBL] [Abstract][Full Text] [Related]
5. A versatile adeno-associated virus vector producer cell line method for scalable vector production of different serotypes.
Yuan Z; Qiao C; Hu P; Li J; Xiao X
Hum Gene Ther; 2011 May; 22(5):613-24. PubMed ID: 21186998
[TBL] [Abstract][Full Text] [Related]
6. High-yield recombinant adeno-associated viral vector production by multivariate optimization of bioprocess and transfection conditions.
Coplan L; Zhang Z; Ragone N; Reeves J; Rodriguez A; Shevade A; Bak H; Tustian AD
Biotechnol Prog; 2024; 40(3):e3445. PubMed ID: 38450973
[TBL] [Abstract][Full Text] [Related]
7. Scalable Production and Purification of Adeno-Associated Viral Vectors (AAV).
Blessing D; Déglon N; Schneider BL
Methods Mol Biol; 2018; 1850():259-274. PubMed ID: 30242692
[TBL] [Abstract][Full Text] [Related]
8. OneBac 2.0: Sf9 Cell Lines for Production of AAV1, AAV2, and AAV8 Vectors with Minimal Encapsidation of Foreign DNA.
Mietzsch M; Hering H; Hammer EM; Agbandje-McKenna M; Zolotukhin S; Heilbronn R
Hum Gene Ther Methods; 2017 Feb; 28(1):15-22. PubMed ID: 28125901
[TBL] [Abstract][Full Text] [Related]
9. Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression.
Earley LF; Conatser LM; Lue VM; Dobbins AL; Li C; Hirsch ML; Samulski RJ
Hum Gene Ther; 2020 Feb; 31(3-4):151-162. PubMed ID: 31914802
[TBL] [Abstract][Full Text] [Related]
10. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
[TBL] [Abstract][Full Text] [Related]
11. Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery.
Chahal PS; Schulze E; Tran R; Montes J; Kamen AA
J Virol Methods; 2014 Feb; 196():163-73. PubMed ID: 24239634
[TBL] [Abstract][Full Text] [Related]
12. Standardized, Scalable, and Timely Flexible Adeno-Associated Virus Vector Production Using Frozen High-Density HEK-293 Cell Stocks and CELLdiscs.
Strobel B; Zuckschwerdt K; Zimmermann G; Mayer C; Eytner R; Rechtsteiner P; Kreuz S; Lamla T
Hum Gene Ther Methods; 2019 Feb; 30(1):23-33. PubMed ID: 30693792
[TBL] [Abstract][Full Text] [Related]
13. Only a small fraction of cells produce assembled capsids during transfection-based manufacturing of adeno-associated virus vectors.
Dash S; Sharon DM; Mullick A; Kamen AA
Biotechnol Bioeng; 2022 Jun; 119(6):1685-1690. PubMed ID: 35182435
[TBL] [Abstract][Full Text] [Related]
14. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale.
Lock M; Alvira M; Vandenberghe LH; Samanta A; Toelen J; Debyser Z; Wilson JM
Hum Gene Ther; 2010 Oct; 21(10):1259-71. PubMed ID: 20497038
[TBL] [Abstract][Full Text] [Related]
15. Transient transfection methods for clinical adeno-associated viral vector production.
Wright JF
Hum Gene Ther; 2009 Jul; 20(7):698-706. PubMed ID: 19438300
[TBL] [Abstract][Full Text] [Related]
16. Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System.
Adamson-Small L; Potter M; Byrne BJ; Clément N
Hum Gene Ther Methods; 2017 Feb; 28(1):1-14. PubMed ID: 28117600
[TBL] [Abstract][Full Text] [Related]
17. High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells.
Hildinger M; Baldi L; Stettler M; Wurm FM
Biotechnol Lett; 2007 Nov; 29(11):1713-21. PubMed ID: 17636388
[TBL] [Abstract][Full Text] [Related]
18. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
19. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography.
Tamayose K; Hirai Y; Shimada T
Hum Gene Ther; 1996 Mar; 7(4):507-13. PubMed ID: 8800745
[TBL] [Abstract][Full Text] [Related]
20. Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.
Naso MF; Tomkowicz B; Perry WL; Strohl WR
BioDrugs; 2017 Aug; 31(4):317-334. PubMed ID: 28669112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
